SCHEMBL4458281

SCHEMBL4458281

C#CCN(c1cnc(N(CC)CC)nc1Nc1[c]c(OC(=O)N(C)C)ccc1)S(=O)(=O)c1ccc(F)cc1

nearest known ligand 0.53

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 15/20 0.53
ITGA4 P13612 15/20 0.53
ITGB7 P26010 13/20 0.53
ITGAV P06756 1/20 0.53
KDM4E B2RXH2 1/20 0.32
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
RAB9A P51151 1/20 0.32
KEAP1 Q14145 3/20 0.32
NFE2L2 Q16236 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4566570 0.91 ITGB1 (0.44) ITGB1ITGA4ITGB7ITGAVKDM4E
SCHEMBL4453759 0.87 ITGB1 (0.41) ITGB1ITGA4ITGB7ITGAVKDM4E
SCHEMBL4457975 0.87 ITGB1 (0.39) ITGB1ITGA4ITGB7ITGAV
SCHEMBL4448892 0.85 ITGB1 (0.38) ITGB1ITGA4ITGB7ITGAV
SCHEMBL2769194 0.85 ITGB1 (0.50) ITGB1ITGA4ITGB7ITGAVKDM4E
SCHEMBL4564578 0.83 ITGB1 (0.40) ITGB1ITGA4ITGB7ITGAV
SCHEMBL4451903 0.82 ITGB1 (0.36) ITGB1ITGA4ITGB7ITGAVALDH1A1
SCHEMBL4458135 0.81 ITGB1 (0.38) ITGB1ITGA4ITGB7ITGAV
SCHEMBL4453860 0.80 ITGB1 (0.38) ITGB1ITGA4ITGB7ITGAVALDH1A1
SCHEMBL5993705 0.80 ITGB1 (0.61) ITGB1ITGA4ITGB7ITGAV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1635822-A4 METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS ELAN PHARM INC (US) 2009-06-24 EP disclosed
EP-1635822-A2 METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS Elan Pharmaceuticals, Inc. (US) 2006-03-22 EP disclosed
WO-2005000246-A2 METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS ELAN PHARMACEUTICALS, INC. (US) 2005-01-06 WO disclosed